| Report Title | Price | Action |
|---|---|---|
| Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021
Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021 Summary Acute Respiratory Failure (Respiratory) - Drugs in Development, 2021 pr...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cystic Fibrosis Transmembrane Conductance Regulator (ATP Binding Cassette Sub Family C Member 7 or Channel Conductance Controlling ATPase Camp Dependent Chloride Channel or ABCC7 or CFTR or EC 5.6.1.6) - Drugs in Development, 2021
Cystic Fibrosis Transmembrane Conductance Regulator (ATP Binding Cassette Sub Family C Member 7 or Channel Conductance Controlling ATPase Camp Depende...
Published: Apr-2021 | No. of Pages: 120
|
$ 3000 | |
| Beta Adrenergic Receptor (ADRB) - Drugs in Development, 2021
Beta Adrenergic Receptor (ADRB) - Drugs in Development, 2021 Summary Beta Adrenergic Receptor (ADRB) - Drugs in Development, 2021 provides in depth ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Drugs in Development, 2021
Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Drugs in Development, 2021 Summary Prostaglandin E2 Receptor EP2 Subtype...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021
Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in Development, 2021 Summary Chemotherapy-Induced Diarrhea (CID) (Toxicology) - Drugs in De...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) - Drugs in Development, 2021
Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor or ADRB2) - Drugs in Development, 2021 Summary Beta 2 Adrenergic Receptor (Beta 2 Adrenoreceptor o...
Published: Apr-2021 | No. of Pages: 120
|
$ 3000 | |
| Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) - Drugs in Development, 2021
Beta Glucuronidase (Beta G1 or Beta D Glucuronidase or GUSB or EC 3.2.1.31) - Drugs in Development, 2021 Summary Beta Glucuronidase (Beta G1 or Beta...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Vasopressin V1b Receptor (AVPR V1b or AVPR V3 or Antidiuretic Hormone Receptor 1b or Vasopressin V3 Receptor or AVPR3 or AVPR1B) - Drugs in Development, 2021
Vasopressin V1b Receptor (AVPR V1b or AVPR V3 or Antidiuretic Hormone Receptor 1b or Vasopressin V3 Receptor or AVPR3 or AVPR1B) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Born Small For Gestational Age (SGA) (Women's Health) - Drugs in Development, 2021
Born Small For Gestational Age (SGA) (Women's Health) - Drugs in Development, 2021 Summary Born Small For Gestational Age (SGA) (Women's Health) - D...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) - Drugs in Development, 2021
Adenosine Monophosphate Activated Protein Kinase ([Hydroxymethylglutaryl CoA Reductase (NADPH)] Kinase or AMPK or EC 2.7.11.31) - Drugs in Development...
Published: Apr-2021 | No. of Pages: 120
|
$ 3000 | |
| C-C Motif Chemokine 2 (HC11 or Monocyte Chemoattractant Protein 1 or Monocyte Chemotactic And Activating Factor or MCAF or Monocyte Chemotactic Protein 1 or Monocyte Secretory Protein JE or Small Inducible Cytokine A2 or CCL2) - Drugs in Development, 2021
C-C Motif Chemokine 2 (HC11 or Monocyte Chemoattractant Protein 1 or Monocyte Chemotactic And Activating Factor or MCAF or Monocyte Chemotactic Protei...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Oxysterols Receptor LXR Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or Ubiquitously Expressed Nuclear Receptor or LXRB or NR1H2) - Drugs in Development, 2021
Oxysterols Receptor LXR Beta (Liver X Receptor Beta or Nuclear Receptor NER or Nuclear Receptor Subfamily 1 Group H Member 2 or Ubiquitously Expressed...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Menopausal Disorders (Women's Health) - Drugs in Development, 2021
Menopausal Disorders (Women's Health) - Drugs in Development, 2021 Summary Menopausal Disorders (Women's Health) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2.7.10.1) - Drugs in Development, 2021
Cells Expressing Epidermal Growth Factor Receptor (Proto Oncogene c ErbB 1 or Receptor Tyrosine Protein Kinase erbB 1 or HER1 or ERBB1 or EGFR or EC 2...
Published: Apr-2021 | No. of Pages: 130
|
$ 3000 | |
| Calcium Activated Potassium Channel - Drugs in Development, 2021
Calcium Activated Potassium Channel - Drugs in Development, 2021 Summary Calcium Activated Potassium Channel - Drugs in Development, 2021 provides i...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Drugs in Development, 2021
Tyrosine Protein Kinase BTK (Bruton Tyrosine Kinase or B Cell Progenitor Kinase or Agammaglobulinemia Tyrosine Kinase or BTK or EC 2.7.10.2) - Drugs i...
Published: Apr-2021 | No. of Pages: 125
|
$ 3000 | |
| Cardiovascular Inflammation (Cardiovascular) - Drugs in Development, 2021
Cardiovascular Inflammation (Cardiovascular) - Drugs in Development, 2021 Summary Cardiovascular Inflammation (Cardiovascular) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) - Drugs in Development, 2021
Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF/SF Receptor or Scatter Factor Receptor or MET or EC 2.7....
Published: Apr-2021 | No. of Pages: 130
|
$ 3000 | |
| Calcium Sensing Receptor - Drugs in Development, 2021
Calcium Sensing Receptor - Drugs in Development, 2021 Summary Calcium Sensing Receptor - Drugs in Development, 2021 provides in depth analysis on Ca...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
| Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC 4.2.1.1) - Drugs in Development, 2021
Carbonic Anhydrase 9 (Carbonate Dehydratase IX or pMW1 or Membrane Antigen MN or P54/58N or Renal Cell Carcinoma Associated Antigen G250 or CA9 or EC ...
Published: Apr-2021 | No. of Pages: 40
|
$ 3000 |